Medical/Pharmaceuticals
icotec Receives FDA Clearance for the CMORE® CT System, Expanding its BlackArmor® Engineered Carbon/PEEK Technology to the Posterior Cervicothoracic Spine
ALTSTÄTTEN, Switzerland and BOSTON, Nov. 14, 2025 /PRNewswire/ -- icotec, the
pioneer of implantable devices made fromBlackArmor® Engineered Carbon/PEEK,
today announced that the U.S. Food and Drug Administration (FDA) has cleared
the CMORE® CT System for use in the cervicothoracic spine.
2025-11-14 00:19
1874
Datasea Reports First Quarter Gross Profit of $1.2 Million, a 4.9x Increase Year-Over-Year in its Strategy to Achieve High-Tech Product Profitability
Gross Margin Rose to 8.5% through High-Tech Products Mix and Cost Efficiencies BEIJING, Nov. 13, 2025 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), aNevada-based high-tech enterprise engaged in acoustic technologies and AI multimodal digitalization, today announces its...
2025-11-13 22:31
4981
LISCure Expands Global Partnerships for BBB Shuttle Platform 'ExoPN-101'; Signs Fourth MTA with Leading Pharma Partner
SEOUL, South Korea, Nov. 13, 2025 /PRNewswire/ -- LISCure Biosciences ("LISCure"), a biotechnology company advancing next-generation therapeutics, today announced that it has entered into a new Material Transfer Agreement (MTA) with a leading global pharmaceutical company for its proprietary blo...
2025-11-13 21:00
2264
HKSH Medical Group Hosts Hong Kong's First Asia-Oceania Particle Therapy Co-operative Group Conference
Uniting Global Proton Therapy Leaders to Advance Precision Cancer Treatment HONG KONG, Nov. 13, 2025 /PRNewswire/ -- Hosted by The Li Shu Fan Medical Foundation and HKSH Medical Group (HKSH), and organised by the Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO), the 5th Annual Conferen...
2025-11-13 19:22
5587
Clarivate Companies to Watch Report Spotlights Seven Women's Health Startups Shaping the Future of Care
Report highlights emerging biotech innovators advancing new therapies, equity
and investment across reproductive, chronic and mental health
LONDON, Nov. 13, 2025 /PRNewswire/ -- Clarivate Plc
2025-11-13 16:00
2323
Project ACTIVE 2.0 Strengthens Global Collaboration to Advance Cervical Cancer Care in Southeast Asia
CHIANG MAI, Thailand, Nov. 13, 2025 /PRNewswire/ -- A major step forward in regional collaboration for cancer care was announced today with the launch of Project ACTIVE 2.0 (Advancing Cervical Cancer Treatment & Patient Recovery Across Southeast Asia), a multi-country initiative that aims to stren...
2025-11-13 15:40
2011
KHB Showcases the Enhanced FOCUS PEGASUS MF200 -- Redefining Efficiency in Veterinary Diagnostics
XI'AN, China, Nov. 13, 2025 /PRNewswire/ -- Guangzhou Focus Biotechnology Co., Ltd., a subsidiary of KHB Group and an innovator in veterinary point-of-care testing (POCT) solutions, presents the enhanced FOCUS PEGASUS MF200 Automatic Multifunctional Veterinary Analyzer — a next-generation system ...
2025-11-13 15:18
2606
Travelers from Singapore Can Now Access 24/7 Multilingual Online Doctor Consultations in Japan -- M3 Career's HOTEL de DOCTOR 24 Provides Peace of Mind During Unexpected Illness
TOKYO, Nov. 13, 2025 /PRNewswire/ -- HOTEL de DOCTOR 24, a specialized online medical consultation service provided by M3 Career, Inc., offers seamless 24-hour access to healthcare for international travelers facing difficulties obtaining medical care inJapan. While HOTEL de DOCTOR 24 has been av...
2025-11-13 15:00
2329
Agilent and National Heart Centre Singapore Sign Agreement to Advance Metabolic Heart Failure Research
Research focuses on human cardiac organoids to uncover metabolic drivers of
heart failure and accelerate new therapeutic strategies to improve
cardiovascular outcomes
SINGAPORE, Nov. 13, 2025 /PRNewswire/ -- Agilent Technologies Inc.
2025-11-13 12:05
2357
Medical AI Company VUNO Reports Profit in Q3, Driven by DeepCARS Growth
- 11 Consecutive Quarters of Revenue Growth; Q3 Revenue Exceeds KRW 10 billion for the First Time SEOUL, South Korea, Nov. 12, 2025 /PRNewswire/ -- VUNO Inc., a global medical AI company, announced that it was profitable in the third quarter of 2025, recording consolidated revenue ofKRW 10.8 bil...
2025-11-13 09:47
1923
Ascletis Announces Co-formulation of ASC36, Once-Monthly Next-Generation Amylin Receptor Agonist and ASC35, Once-Monthly Next-Generation GLP-1R/GIPR Dual Agonist for Clinical Development
- Using Ascletis' proprietary Ultra-Long-Acting Platform technology, co-formulation of ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist and ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist, demonstrated a comparable pharmacokinet...
2025-11-13 07:30
3530
Laronix Secures $3.2 Million Grant from the Australian Government to Bring its AI-Powered Voice Technology to the Market
BRISBANE, Australia, Nov. 13, 2025 /PRNewswire/ -- Laronix
2025-11-13 06:30
2654
Focusing on Industrialisation and Exploring Global Pathways -- The 3rd CREATE Symposium Concludes Successfully
HONG KONG, Nov. 12, 2025 /PRNewswire/ -- How is artificial intelligence revolutionising diagnostic experiences? How can robotics enhance surgical precision? How far are we from achieving universal access to medical AI? What are the latest trends and future directions in medical technology develo...
2025-11-12 21:20
2057
Medit and OraQ Announce Strategic Partnership to Advance AI-Driven Intelligence in Digital Dentistry
Collaboration unites two leaders in innovation to redefine how clinical insight is delivered across the dental ecosystem NEWPORT BEACH, Calif., Nov. 12, 2025 /PRNewswire/ -- Medit, a global leader in 3D intraoral scanning solutions, and OraQ, a pioneer in AI-powered clinical intelligence, today ...
2025-11-12 21:00
4227
EirGenix Signed The Commercial Licensing Agreement for Its Second HER2 Biosimilar Asset EG1206A
TAIPEI, Nov. 12, 2025 /PRNewswire/ -- EirGenix Inc.(TWSE: 6589) today announced that it has entered into a second global exclusive licensing agreement with international biosimilar leader Sandoz AG (SIX:SDZ/OTCQX:SDZNY) for the commercialization of its independently developed breast cancer biosim...
2025-11-12 20:47
2416
EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2 Biosimilar Asset EG1206A
TAIPEI, Nov. 12, 2025 /PRNewswire/ -- EirGenix Inc.(TWSE: 6589) today announced that it has entered into a second global exclusive licensing agreement with international biosimilar leader Sandoz AG (SIX:SDZ/OTCQX:SDZNY) for the commercialization of its independently developed breast cancer biosim...
2025-11-12 16:12
1811
Vieworks Completes Major Expansion of Hwaseong Manufacturing Site, Doubling Production Capacity
Strategic Infrastructure Growth Positions Vieworks at the Forefront of Global Imaging Innovation ANYANG, South Korea, Nov. 12, 2025 /PRNewswire/ -- Vieworks, a global leader in advanced X-ray imaging and industrial vision systems, has announced the successful completion of a large-scale expansio...
2025-11-12 10:44
3907
Alpha IVF Singapore uses Advanced Fertility Genomic Screening and Artificial Intelligence Embryo Scoring to help couples become parents
SINGAPORE, Nov. 12, 2025 /PRNewswire/ -- In-vitro fertilisation (IVF) has become increasingly prominent due to societal shifts towards delayed childbearing, infertility issues, and advances in medical technology that have improved success rates. At Alpha IVF Singapore, Advanced Fertility Genomic ...
2025-11-12 10:00
1782
John Chuang and Onyx Healthcare Inc. Honored with Dual Wins at the Asia Pacific Enterprise Awards (APEA) 2025 Taiwan Chapter
TAIPEI, Nov. 12, 2025 /PRNewswire/ -- Onyx Healthcare Inc., a global leader in medical AI computing and healthcare device manufacturing, proudly celebrates its dual victory at the Asia Pacific Enterprise Awards (APEA) 2025 Taiwan Chapter, receiving accolades under the Corporate Excellence and Mas...
2025-11-12 09:00
1409
CureGene Unveils Groundbreaking Preclinical Data for CG-0416, a Novel Oral Non-GLP-1 Therapy, at Obesity Week 2025
CG-0416, a highly liver-targeted THR-β agonist, demonstrates high-quality weight loss by reducing fat mass while preserving muscle, both as a monotherapy and in combination withGLP-1 RAs. ATLANTA, Nov. 11, 2025 /PRNewswire/ -- CureGene Pharmaceuticals ("CureGene") today announced the first discl...
2025-11-12 06:24
3144
Week's Top Stories
Most Reposted
TD Brings its Global Asset Management Businesses Under One Name
[Picked up by 1168 media titles]
2026-11-02 20:00OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1129 media titles]
2026-11-05 06:52Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1082 media titles]
2026-11-03 22:00Fintech OPay Raises $304 Million Ahead of NYSE Debut: NYSE Content Update
[Picked up by 1079 media titles]
2026-10-30 22:34
H.E. Ahmed Al-Khateeb, Saudi Minister of Tourism, Inaugurates Saudi Land at WTM London 2026, Reinforcing Saudi's Commitment to Global Travel Trade
[Picked up by 1067 media titles]
2026-11-04 07:31
Most Read
1B views since June: Coda and TikTok Gaming turn content into commerce
2026-11-02 09:35
62639
Airbrush Upgrades AI Image Enhancer With 16K Output and Batch Processing for Up to 50 Images
2026-11-03 02:00
58637
iQIYI Launches China's First AI Film Studio in Shanghai, with Inaugural Title "Cop in Trouble" in Production
2026-11-02 09:52
55754
Korean Derma Skincare Brand MDP+ Launches at Nordstrom
2026-11-03 00:30
25227
